News

Researchers have developed the ALA-CART platform to enhance CAR T cell therapy’s effectiveness against antigen-low leukemias.

New research has confirmed that automated insulin delivery (AID) systems are both safe and effective for older adults with Type 1 diabetes.

Using a large-scale prospective design, this study analysed accelerometer data from 73,411 participants collected between 2013–2015.

A large-scale study finds that the hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic hepatitis B.

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

While patients with rheumatoid arthritis have a lower overall cancer incidence rate, they face higher post-cancer mortality.

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

A large-scale genomic surveillance study has found that resistance to nirsevimab in infants remains rare despite widespread use.